This inventor holds 25 USPTO granted patents and 3 published patent applications, plus 6 CIPO patents and 7 EPO patents, primarily in P2X7 Receptor Therapy. Top assignees: Biosceptre International Limited, Biosceptre (Aust) Pty Ltd, Intreat Pty Limited. Active years: 2008-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New South Wales, AU (2011)
- North Ryde, AU (2008 - 2020)
Company Filing History:
11 out of 12 
10 out of 17 
3 out of 3 Years Active: 2008-2020
Areas of Expertise:
Title: Innovations in Cancer Treatment: The Contributions of Angus Gidley-Baird
Introduction: Angus Gidley-Baird, based in North Ryde, Australia, is a distinguished inventor in the field of biotechnology with a remarkable portfolio of 25 patents. His innovative approaches to cancer treatment have the potential to influence therapeutic strategies and improve patient outcomes significantly.
Latest Patents: Among his latest patents, two notable inventions focus on P2X7 peptides. The first patent, "Methods of treating cancer with a P2X7 peptide," revolves around purinergic receptors, particularly P2X7 receptors. This invention details the generation of antibodies that selectively bind to non ATP-binding P2X7 receptors, offering novel detection and treatment options for cancer. The second patent, "Combination therapy utilizing P2X7 peptides," addresses how to produce a humoral response to P2X7 receptors in individuals with cancer, aiming to minimize cancer progression in these patients.
Career Highlights: Throughout his career, Angus has been associated with various organizations that emphasize advancing cancer research and treatment methodologies. His work with leading biotechnology companies has helped bridge the gap between innovative research and practical applications in medical therapies.
Collaborations: Angus has collaborated with notable peers in the industry, including Julian Alexander Barden and Glenn Ronald Pilkington. These collaborations highlight the importance of teamwork in advancing scientific research and innovation.
Conclusion: Angus Gidley-Baird's inventive contributions to the field of cancer treatment through his patents on P2X7 peptides showcase his commitment to improving therapeutic options for patients. His work emphasizes the critical intersection of research and innovation that can lead to breakthroughs in combating cancer and enhancing the quality of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile